AVLN - Company ID 0001540171
The table below shows Avalyn Pharma Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 |
|---|---|
| Cash & equivalents | $92.31M |
| Short-term investments | $30.82M |
| Receivables | - |
| Inventory | - |
| Total current assets | $129.99M |
| Property, plant & equipment | $1.26M |
| Goodwill | - |
| Total assets | $135.66M |
| Accounts payable | $3.15M |
| Total current liabilities | $11.79M |
| Long-term debt | $14.81M |
| Total liabilities | $27.69M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Retained earnings |
| -$292.23M |
| Total equity | -$264.25M |